AU5299998A – Opioid formulations having extended controlled release
– Google Patents
AU5299998A – Opioid formulations having extended controlled release
– Google Patents
Opioid formulations having extended controlled release
Info
Publication number
AU5299998A
AU5299998A
AU52999/98A
AU5299998A
AU5299998A
AU 5299998 A
AU5299998 A
AU 5299998A
AU 52999/98 A
AU52999/98 A
AU 52999/98A
AU 5299998 A
AU5299998 A
AU 5299998A
AU 5299998 A
AU5299998 A
AU 5299998A
Authority
AU
Australia
Prior art keywords
controlled release
opioid formulations
extended controlled
extended
opioid
Prior art date
1991-12-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU52999/98A
Other versions
AU716793B2
(en
Inventor
Mark Chasin
Paul Goldenheim
Robert Kaiko
Benjamin Oshlack
Frank Pedi
Richard Sackler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1991-12-24
Filing date
1998-02-06
Publication date
1998-03-26
Family has litigation
First worldwide family litigation filed
litigation
Critical
https://patents.darts-ip.com/?family=25635004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU5299998(A)
“Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
1994-06-29
Priority claimed from AU66058/94A
external-priority
patent/AU6605894A/en
1998-02-06
Application filed by Euro Celtique SA
filed
Critical
Euro Celtique SA
1998-02-06
Priority to AU52999/98A
priority
Critical
patent/AU716793B2/en
1998-03-26
Publication of AU5299998A
publication
Critical
patent/AU5299998A/en
2000-03-09
Application granted
granted
Critical
2000-03-09
Publication of AU716793B2
publication
Critical
patent/AU716793B2/en
2012-12-08
Anticipated expiration
legal-status
Critical
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
A61K9/1605—Excipients; Inactive ingredients
A61K9/1629—Organic macromolecular compounds
A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
A61K31/47—Quinolines; Isoquinolines
A61K31/485—Morphinan derivatives, e.g. morphine, codeine
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
A61K31/52—Purines, e.g. adenine
A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
A61K9/1605—Excipients; Inactive ingredients
A61K9/1617—Organic compounds, e.g. phospholipids, fats
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/20—Pills, tablets, discs, rods
A61K9/2004—Excipients; Inactive ingredients
A61K9/2013—Organic compounds, e.g. phospholipids, fats
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/20—Pills, tablets, discs, rods
A61K9/2004—Excipients; Inactive ingredients
A61K9/2022—Organic macromolecular compounds
A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/20—Pills, tablets, discs, rods
A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/20—Pills, tablets, discs, rods
A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/20—Pills, tablets, discs, rods
A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/20—Pills, tablets, discs, rods
A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
A61K9/2806—Coating materials
A61K9/2833—Organic macromolecular compounds
A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
AU52999/98A
1991-12-24
1998-02-06
Opioid formulations having extended controlled release
Expired
AU716793B2
(en)
Priority Applications (1)
Application Number
Priority Date
Filing Date
Title
AU52999/98A
AU716793B2
(en)
1991-12-24
1998-02-06
Opioid formulations having extended controlled release
Applications Claiming Priority (4)
Application Number
Priority Date
Filing Date
Title
US214111
1991-12-24
US8624893A
1993-07-01
1993-07-01
AU66058/94A
AU6605894A
(en)
1991-12-24
1994-06-29
Opiod formulations having extended controlled release
AU52999/98A
AU716793B2
(en)
1991-12-24
1998-02-06
Opioid formulations having extended controlled release
Related Parent Applications (1)
Application Number
Title
Priority Date
Filing Date
AU66058/94A
Division
AU6605894A
(en)
1991-12-24
1994-06-29
Opiod formulations having extended controlled release
Publications (2)
Publication Number
Publication Date
AU5299998A
true
AU5299998A
(en)
1998-03-26
AU716793B2
AU716793B2
(en)
2000-03-09
Family
ID=25635004
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU52999/98A
Expired
AU716793B2
(en)
1991-12-24
1998-02-06
Opioid formulations having extended controlled release
Country Status (1)
Country
Link
AU
(1)
AU716793B2
(en)
1998
1998-02-06
AU
AU52999/98A
patent/AU716793B2/en
not_active
Expired
Also Published As
Publication number
Publication date
AU716793B2
(en)
2000-03-09
Similar Documents
Publication
Publication Date
Title
EG20650A
(en)
1999-10-31
Opioid formulations having extended controlled release
AU2746992A
(en)
1993-05-06
Controlled release pharmaceutical compositions
AU8131191A
(en)
1992-01-30
Sustained release formulations
AU1118092A
(en)
1992-09-10
Sustained release compositions
AU1802492A
(en)
1992-12-24
New aqueous formulations
AU6018194A
(en)
1995-08-01
Easy intubator
AU659473B2
(en)
1995-05-18
Slow release compositions
GB9207832D0
(en)
1992-05-27
Formulations
GB2252043B
(en)
1994-10-12
Controlled release compositions
AU1975092A
(en)
1993-01-12
Compounds
AU2390792A
(en)
1993-03-02
Thienopyrimidin-4-one derivative
AU2933092A
(en)
1993-06-15
Pyrazoleglycolamide derivative
AU1405192A
(en)
1993-03-25
Anchor release mechanism
AU1732692A
(en)
1992-12-10
Substituted imidazolinylpyrimidines
AU2449592A
(en)
1993-03-16
4-acylaminoimidazole derivative
AU658903B2
(en)
1995-05-04
Snake-controlling agent
AU1101592A
(en)
1992-08-20
Oxazinobenzazole compounds
AU5299998A
(en)
1998-03-26
Opioid formulations having extended controlled release
AU2674292A
(en)
1993-05-21
Thioformamide derivative
AU3106393A
(en)
1993-07-08
Rod-matic release
AU1888092A
(en)
1993-01-08
Aminoalkylthiazole derivative
AU2072092A
(en)
1993-02-04
A87689 compounds
AU1130292A
(en)
1992-09-03
Peptid-analoga
AU8996291A
(en)
1993-07-08
Pharmaceutical formulations
GB9100234D0
(en)
1991-02-20
Controlled release preparation
Legal Events
Date
Code
Title
Description
2000-07-06
CB
Opposition lodged by
Opponent name:
GRUNENTHAL GMBH
